Michelle R. Padget

1.4k total citations
22 papers, 1.0k citations indexed

About

Michelle R. Padget is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Michelle R. Padget has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 15 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Michelle R. Padget's work include Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (9 papers) and Immune Cell Function and Interaction (9 papers). Michelle R. Padget is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (9 papers) and Immune Cell Function and Interaction (9 papers). Michelle R. Padget collaborates with scholars based in United States, Australia and United Kingdom. Michelle R. Padget's co-authors include James W. Hodge, Jeffrey Schlom, Patrick Soon‐Shiong, Shahrooz Rabizadeh, Kellsye P. Fabian, Clint Allen, Carter Van Waes, Rika Fujii, Kristen Solocinski and So Jin Park and has published in prestigious journals such as Blood, Clinical Cancer Research and eLife.

In The Last Decade

Michelle R. Padget

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle R. Padget United States	15	724	579	267	85	75	22	1.0k
Marco Greppi Italy	13	692 1.0×	946 1.6×	228 0.9×	85 1.0×	131 1.7×	24	1.3k
Sylvie Rusakiewicz France	22	800 1.1×	800 1.4×	322 1.2×	168 2.0×	118 1.6×	44	1.4k
Iva Truxová Czechia	16	648 0.9×	729 1.3×	299 1.1×	104 1.2×	94 1.3×	24	1.2k
Troels Holz Borch Denmark	19	879 1.2×	738 1.3×	202 0.8×	75 0.9×	45 0.6×	42	1.1k
Anthony Miliotto United States	13	559 0.8×	570 1.0×	255 1.0×	63 0.7×	65 0.9×	23	866
Wouter Scheper Netherlands	11	773 1.1×	924 1.6×	310 1.2×	55 0.6×	62 0.8×	15	1.3k
Weiyun Z. Ai United States	18	977 1.3×	700 1.2×	207 0.8×	80 0.9×	35 0.5×	64	1.5k
Lorenzo F. Fanchi Netherlands	11	725 1.0×	592 1.0×	222 0.8×	76 0.9×	98 1.3×	17	1.1k
Ana Pilar González Spain	17	524 0.7×	491 0.8×	164 0.6×	65 0.8×	31 0.4×	45	1.0k
Christine Alewine United States	18	517 0.7×	395 0.7×	295 1.1×	299 3.5×	97 1.3×	51	1.1k

Countries citing papers authored by Michelle R. Padget

Since Specialization

Citations

This map shows the geographic impact of Michelle R. Padget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle R. Padget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle R. Padget more than expected).

Fields of papers citing papers by Michelle R. Padget

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle R. Padget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle R. Padget. The network helps show where Michelle R. Padget may publish in the future.

Co-authorship network of co-authors of Michelle R. Padget

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle R. Padget. A scholar is included among the top collaborators of Michelle R. Padget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle R. Padget. Michelle R. Padget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fabian, Kellsye P., Ginette S. Santiago-Sánchez, Michelle R. Padget, et al.. (2024). Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models. Journal for ImmunoTherapy of Cancer. 12(10). e009712–e009712. 3 indexed citations

Hoke, Austin T.K., Yoko Takahashi, Michelle R. Padget, et al.. (2024). Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach. Translational Oncology. 44. 101943–101943. 2 indexed citations

Fabian, Kellsye P., Michelle R. Padget, Yvette Robbins, et al.. (2024). Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence. Frontiers in Oncology. 14. 1376622–1376622. 3 indexed citations

Franks, S. Elizabeth, Ginette S. Santiago-Sánchez, Kellsye P. Fabian, et al.. (2023). Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12. Cancer Immunology Immunotherapy. 72(8). 2783–2797. 4 indexed citations

Fabian, Kellsye P., Michelle R. Padget, Clint Allen, et al.. (2022). Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies. Journal for ImmunoTherapy of Cancer. 10(12). e005752–e005752. 6 indexed citations

Hoke, Austin T.K., Michelle R. Padget, Kellsye P. Fabian, et al.. (2021). Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells. Cancer Research Communications. 1(3). 127–139. 14 indexed citations

Lee, Maxwell, Yvette Robbins, Cem Sievers, et al.. (2021). Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells. Journal for ImmunoTherapy of Cancer. 9(3). e002128–e002128. 34 indexed citations

Wolfson, Benjamin, Michelle R. Padget, Jeffrey Schlom, & James W. Hodge. (2021). Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing. Journal for ImmunoTherapy of Cancer. 9(7). e002258–e002258. 18 indexed citations

Fabian, Kellsye P., Anthony S. Malamas, Michelle R. Padget, et al.. (2020). Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable. Cancer Immunology Research. 9(2). 239–252. 11 indexed citations

10.

Lampert, Erika J., Alexandra S. Zimmer, Michelle R. Padget, et al.. (2020). Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study. Clinical Cancer Research. 26(16). 4268–4279. 150 indexed citations

11.

Robbins, Yvette, Sarah Greene, Jay Friedman, et al.. (2020). Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells. eLife. 9. 43 indexed citations

12.

Fabian, Kellsye P., Michelle R. Padget, Renee N. Donahue, et al.. (2020). PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations. Journal for ImmunoTherapy of Cancer. 8(1). e000450–e000450. 126 indexed citations

13.

Park, So Jin, Wenda Ye, Roy Xiao, et al.. (2019). Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer. Oral Oncology. 95. 127–135. 135 indexed citations

14.

Friedman, Jay, Michelle R. Padget, J. Jack Lee, et al.. (2019). Direct and antibody-dependent cell-mediated cytotoxicity of head and neck squamous cell carcinoma cells by high-affinity natural killer cells. Oral Oncology. 90. 38–44. 21 indexed citations

15.

Friedman, Jay, Megan V. Morisada, Lillian Sun, et al.. (2018). Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies. Journal for ImmunoTherapy of Cancer. 6(1). 59–59. 43 indexed citations

16.

Padget, Michelle R., Benjamin Wolfson, Sofia R. Gameiro, et al.. (2018). Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition. Journal for ImmunoTherapy of Cancer. 6(1). 133–133. 48 indexed citations

17.

Sasaki, Takayo, Juan Carlos Rivera‐Mulia, Daniel L. Vera, et al.. (2017). Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia. Experimental Hematology. 51. 71–82.e3. 21 indexed citations

18.

Jochéms, Caroline, James W. Hodge, Massimo Fantini, et al.. (2016). An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele. Oncotarget. 7(52). 86359–86373. 150 indexed citations

19.

Boyde, Mary, Michelle R. Padget, Elizabeth Burmeister, & Leanne M. Aitken. (2013). In-hospital cardiac arrests: effect of amended Australian Resuscitation Council 2006 guidelines. Australian Health Review. 37(2). 178–184. 7 indexed citations

20.

Cramer-Morales, Kimberly, Margaret Nieborowska-Skorska, Kara Scheibner, et al.. (2013). Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile. Blood. 122(7). 1293–1304. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact